Actinium Pharmaceuticals ATNM
$ 1.26
12.5%
Facebook
Twitter
ВКонтакте
Telegram
Сообщить о неточностиКвартальный отчет 2024-Q3
добавлен 14.11.2024
Actinium Pharmaceuticals Мультипликаторы 2011-2024 | ATNM
Мультипликаторы по годам Actinium Pharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-4.3 | -6.8 | -4.5 | -4.0 | -1.7 | -2.5 | -1.8 | -2.0 | -3.8 | -6.0 | -12.0 | -0.2 | - |
P/S |
2571.7 | 218.9 | 97.1 | - | - | - | - | - | - | - | - | - | - |
EPS |
-1.8 | -1.4 | -1.2 | -1.8 | -4.4 | -0.2 | -0.4 | -0.5 | -0.6 | -0.9 | -0.5 | -7.6 | -4.3 |
EV (Enterprise Value) |
177 млн | 164 млн | 40.1 млн | 31.3 млн | 35 млн | 51.8 млн | 34.8 млн | 33.4 млн | 59.9 млн | 150 млн | 131 млн | 680 тыс. | -5.62 млн |
EBITDA per Share |
-1.92 | -1.38 | -1.19 | -1.91 | -4.35 | -6.73 | -12.1 | -16.6 | -19.5 | -24.6 | -8.68 | -216 | - |
EV/EBITDA |
-1.3 | -1.2 | -1.4 | -1.9 | -1.1 | -1.1 | -2.2 | -6.3 | -18.9 | 0.5 | - | ||
PEG |
0.29 | 0.22 | 0.11 | -0.07 | -0.05 | -0.06 | -0.09 | -0.22 | -0.1 | 0.07 | -0.13 | 0.0 | - |
P/B |
5.7 | 3.4 | 1.5 | 1.5 | 6.8 | 6.7 | 3.5 | 2.7 | 3.7 | -76.7 | -83.2 | 1.4 | - |
P/CF |
-4.4 | 26.1 | -5.3 | -4.1 | -1.8 | -2.9 | -2.2 | -2.4 | -4.4 | -10.2 | -20.6 | -0.3 | - |
ROE % |
-134.19 | -49.66 | -33.69 | -36.23 | -387.97 | -268.40 | -194.58 | -135.06 | -95.68 | 1284.12 | 690.83 | -729.83 | - |
ROA % |
-59.94 | -28.91 | -30.82 | -33.46 | -187.65 | -158.86 | -145.07 | -107.96 | -79.08 | -326.16 | -186.86 | -144.44 | - |
ROCE % |
-142.72 | -51.30 | -33.94 | -36.05 | -348.86 | -269.96 | -196.84 | -149.08 | -113.00 | 1169.32 | 422.42 | -693.70 | - |
Current Ratio |
1.8 | 2.4 | 11.7 | 13.6 | 1.9 | 2.4 | 3.8 | 5.0 | 5.7 | 0.8 | 0.8 | 1.2 | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Операционный цикл |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Финансовый цикл |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Все данные представлены в валюте USD
Мультипликаторы поквартально Actinium Pharmaceuticals
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.37 | -0.38 | -0.31 | - | -0.49 | -0.58 | -0.43 | - | -0.38 | -0.33 | -0.23 | - | -0.3 | -0.25 | -0.29 | - | -0.36 | -0.41 | -0.98 | - | -1.21 | -1 | -0.05 | - | -0.06 | -0.04 | -0.07 | - | -0.09 | -0.12 | -0.14 | - | -0.14 | -0.15 | -0.1 | - | -0.1 | -0.2 | -0.09 | - | -0.21 | 0.14 | -0.66 | - | -0.06 | -0.13 | -0.03 | - | -3.76 | -0.09 | -0.07 | -0.01 | 0.01 | 0.01 | - |
EBITDA per Share |
- | - | -0.34 | - | - | - | -0.44 | - | -0.37 | -0.32 | -0.23 | - | -0.28 | -0.24 | -0.29 | - | -0.34 | -0.39 | -0.96 | - | -1.16 | -0.97 | -0.05 | - | -0.06 | -0.04 | -0.07 | - | -0.09 | -0.12 | -0.14 | - | -0.15 | -0.15 | -0.14 | - | -0.11 | -0.2 | -0.24 | - | -0.25 | -0.17 | -0.16 | - | -0.07 | -0.07 | -0.09 | - | -2.99 | -0.05 | -0.07 | - | - | - | - |
ROE % |
-106.41 | -106.59 | -109.29 | -78.36 | -91.65 | -74.49 | -55.82 | -30.68 | -38.68 | -33.39 | -29.69 | -21.76 | -30.79 | -31.83 | -33.13 | -25.82 | -142.74 | -250.63 | -332.16 | -306.45 | -376.21 | -329.06 | -295.17 | -196.69 | -242.94 | -219.43 | -215.85 | -156.81 | -193.46 | -183.85 | -169.04 | -97.88 | -115.84 | -97.15 | -94.33 | -65.92 | 250.18 | 584.23 | 435.36 | 1001.88 | 1092.99 | 868.01 | 1229.36 | 313.81 | 50.86 | -303.21 | -618.12 | -1129.18 | -1129.58 | -862.46 | -745.58 | -0.40 | 4.17 | -19.51 | - |
ROA % |
-51.46 | -52.30 | -54.99 | -41.07 | -49.18 | -42.36 | -33.42 | -21.37 | -28.97 | -28.46 | -28.03 | -20.63 | -28.98 | -29.72 | -30.74 | -23.85 | -80.40 | -128.60 | -164.71 | -148.21 | -189.50 | -174.25 | -163.83 | -116.42 | -150.90 | -144.09 | -149.90 | -116.91 | -146.20 | -141.01 | -131.95 | -78.24 | -93.08 | -78.63 | -77.30 | -54.48 | -134.77 | -200.21 | -125.70 | -254.47 | -279.12 | -223.48 | -318.20 | -84.88 | -136.92 | -164.31 | -143.02 | -223.47 | -223.53 | -2514.16 | 8479.50 | -0.06 | -2342.67 | 10966.67 | - |
ROCE % |
-116.12 | -116.07 | -117.21 | -82.65 | -96.40 | -77.22 | -57.79 | -31.29 | -39.35 | -33.66 | -29.92 | -21.96 | -31.11 | -32.21 | -33.50 | -26.02 | -143.88 | -252.59 | -335.10 | -308.95 | -379.27 | -331.73 | -297.36 | -198.16 | -247.14 | -225.79 | -222.73 | -158.76 | -198.19 | -188.65 | -174.37 | -111.17 | -132.29 | -113.97 | -109.26 | -90.61 | 275.83 | 663.39 | 927.23 | 811.84 | 915.01 | 651.74 | 516.22 | 327.50 | 118.06 | -194.55 | -362.43 | -370.46 | -370.73 | -158.40 | -77.98 | -0.27 | 2.88 | 7.16 | - |
Current Ratio |
1.9 | 1.9 | 2.0 | 1.8 | 2.0 | 2.1 | 2.3 | 2.4 | 2.6 | 2.8 | 13.0 | 11.8 | 20.1 | 21.4 | 17.2 | 13.1 | 13.1 | 13.1 | 13.1 | 1.9 | 1.9 | 1.9 | 1.9 | 2.5 | 2.5 | 2.5 | 2.5 | 3.9 | 3.9 | 3.9 | 3.9 | 5.0 | 5.0 | 5.0 | 5.0 | 5.8 | 5.8 | 5.8 | 5.8 | 0.8 | 0.8 | 0.8 | 0.8 | 0.8 | 0.8 | 0.8 | - | 1.2 | 1.2 | 1.2 | 61.5 | 73.4 | - | - | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Операционный цикл |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Финансовый цикл |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Все данные представлены в валюте USD